Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Rolling; submission deadlines for subsequent review ocurring on August 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Diamond Blackfan Anemia Foundation – Research Grant

• Due: Rolling
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
• Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.

FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
• Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Hearst Foundations – Funding Priorities in Health

• Due: Rolling
• Funding: $100,000 minimum
• Project period: Not specified
• Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
• Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Malan Syndrome Foundation – Research Grant Program

• Due: Rolling
• Funding: $30,000 per year
• Project period: 1 to 2 years
• Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
• Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals

• Due: Rolling
• Funding: Not specified
• Project Period: 1 to 3 years
• Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
• Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

September

Patient-Centered Outcomes Research Institute (PCORI) – Addressing Rare Diseases PCORI Funding Announcement – Cycle 3 2025

• Due: September 29, 2025 (LOI)
• Funding: Up to $300,000
• Project Period: Up to 2 years
• Purpose: Funding for this initiative supports projects that encourage active, meaningful involvement of patients, families, caregivers and the broader healthcare community as integral members of the patient-centered comparative clinical effectiveness research (CER) enterprise.
• Eligibility: Projects must focus on active dissemination that spreads awareness and increases knowledge of PCORI-funded research findings.

Pfizer and the American College of Emergency Physicians (ACEP) – Enhancing Patient-Centered Outcomes in Emergency Department Migraine Management RFP

• Due: September 29, 2025
• Funding: Up to $200,000
• Project Period: Up to 2 years
• Purpose: To support projects focused on clinical program development that overcome barriers to safe, evidence-based management, disposition, and follow up of this patient population.
• Eligibility: U.S.-based medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement with the target audience being emergency physicians treating adult patients presenting with symptoms of migraine in the ED. PIs must be an employee or contractor of the organization applying.

Bay Area Lyme Foundation  – Research Grants

• Due: September 30, 2025
• Funding: Not specified
• Project Period: Not specified
• Purpose: To support projects focused on research and development of novel diagnostics and treatments for Lyme Disease.
• Eligibility: Applications from universities, hospitals, and independent research entities throughout the U.S. (U.S. only) will be accepted. Previous research experience in Lyme Disease research is not necessary; respected researchers in their fields may leverage their knowledge, abilities, and resourcefulness to develop new concepts, ideas, and methods.

Benign Essential Blepharospasm Foundation – Research Grant

• Due: September 30, 2025
• Funding:stipend Up to $50,000
• Project Period: 1 year
• Purpose: To support research focused on causes, cures, and treatment for blepharospasm.
• Eligibility: Applicants must work at an organization located within the U.S., Canada, or countries where supervision of grant administration is possible. Grantee institution must agree to be bound by the Terms and Conditions of the application.

Lung Cancer Research Foundation (LCRF) – 2025 LCRF – Boehringer Ingelheim Team Science Award on Innovative Therapeutic Strategies to Understand and Treat Lung Cancers Harboring HER2 Mutations RFP

• Due: September 30, 2025 (LOI)
• Funding: $1,500,000
• Project Period: Over 3 years
• Purpose: To support research that will address important mechanistic questions and developmental therapeutics across the care continuum and have the potential to increase survivorship. Proposals must include studies in patients with lung cancer harboring HER2 mutations. It is preferred that a clinical trial be associated with or planned as a result of the findings of the grant. It is also expected that a program of correlative, translational research will be proposed that will enhance the understanding of these oncogenic-driven lung cancers.
• Eligibility: Lead PIs should be senior investigators past the initial five years of their first academic appointment. Eligible teams may be comprised of faculty-level established researchers providing complementary interdisciplinary expertise, each making separate but closely
  integrated contributions to the research being done. Cancer researchers on the team should be primarily affiliated with a non-profit, academic or research institution.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – Advanced Fellowships

• Due: September 30, 2025
• Funding: $75,000
• Project Period: 1 year
• Purpose: To support advanced training for one year in pediatric nutrition for a NASPGHAN member to gain focused clinical research experience.
• Eligibility: NASPGHAN membership for at least 2 years and a mentor is required.
  – NASPGHAN Foundation/Abbott Advanced Fellowship Training In Pediatric Nutrition – researchareas to include but are not limited to fetal growth and neonatal nutrition, typical development of feeding skills/behaviors and feeding disorders; nutritional aspects of eating disorders such as anorexia nervosa and bulimia; malnutrition and failure to thrive; nutrition education; nutrition in specific systemic diseases or clinical states such as cystic fibrosis, liver disease, intestinal failure, and organ transplantation; nutrition support; community nutrition; nutrition epidemiology; energy homeostasis; nutrition and the microbiome; micronutrient homeostasis; nutrigenomics; obesity; breast milk and breast feeding; and basic laboratory nutritional science.
  – NASPGHAN Foundation Advance Fellowship Training in Pediatric Endoscopy – for focused a research/and or quality improvement project in areas including but not limited to Endoscopic retrograde cholangiopancreatography (ERCP) with stenting and/or sphincterotomy, endoscopic ultrasound (EUS), advanced approaches to control GI bleeding (sclerotherapy, argon laser, clips, etc), transnasal endoscopy, peroral endoscopic myotomy (POEM), esophageal or intestinal stricture dilatation, pancreatic pseudocyst drainage, etc.

Wellcome – Early Career Awards

• Due: September 30, 2025
• Funding: Salary and up to £400,000
• Project Period: Up to 5 years (part-time available)
• Purpose: To support advanced training for one year in pediatric nutrition for a NASPGHAN member to gain focused clinical research experience.
• Eligibility: Early career researchers ready to design, plan and deliver their own innovative projects. Applicants must hold a PhD or an equivalent higher research degree or at least four years’ equivalent research experience in the humanities and social sciences. Applicants who have no more than 3 years postdoctoral experience or researchers making a shift to a different research discipline may apply.

October

Pfizer External Research & Grants (ER&G) – Independent Medical Education Request for Proposals (RFP) Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)

• Due: October 1, 2025
• Funding: Up to $10,000 to $250,000
• Project Period: Up 18 months
• Purpose: To support proposals that focus on treatment optimization in the first-line maintenance setting and the evolving MBC therapeutic landscape to increase understanding of the role and value of maintenance therapy to allow clinicians to make informed treatment decisions.
• Eligibility: U.S.-based medical, allied health, and/or pharmacy professional schools; hospitals and healthcare institutions; professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible to apply. Target audience: Community medical oncologists, oncology nurses and nurse practitioners, physician assistants, pharmacists and other healthcare professionals involved in the care and treatment of people with MBC. If continuing education credit will be offered, the requesting organization must be accredited.

Pfizer External Research & Grants (ER&G) – Pfizer IME Grant RFP: Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)

• Due: October 1, 2025
• Funding: $100,000 to $250,000
• Project Period: Up to 2 years
• Purpose: To support independent medical education provider organizations interested in teaching Physician Assistants,Nurse Practitioners and other allied healthcare professionals on the patient care team about advances in the use of biomarkers and genetics to inform treatment decision making in oncology.
• Eligibility: Medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement may apply. Only organizations in the U.S. are eligible to receive grants.

Acoustical Society of American  – 2026-27 F. V. Hunt Postdoctoral Research Fellowship in Acoustics

• Due: October 6, 2025
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: In honor of Dr. Hunt, this award supports advancing the science of, and education in acoustics.
• Eligibility: Applicants must have received a doctoral degree no earlier than 2024 or will be receiving one no later than April of 2026. Membership is required before candidates can apply. Applicants must have permanent residence or citizenship in the United States or Canada at the time of application.

Pfizer and the National Bleeding Disorders Foundation (NBDF) – USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Special Considerations RFP

• Due: October 14, 2025
• Funding: Up to $200,000
• Project Period: Up to 18 months
• Purpose: To support proposals that identify and address the educational requirements of pharmacists and pharmacy technicians focusing on the challenges and opportunities with USP <797> in hospitals and alternate site pharmacies. Primary Area of Interest is patient safety.
• Eligibility: U.S.-based medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small), professional organizations/medical societies, medical education companies, and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible. The target audience for the project should include pharmacists, pharmacy technicians and medication safety officers. Applicants must be the project/program lead or an authorized designee of such individual (e.g., the project/program lead’s grant coordinator). Accreditation is necessary for projects offering continuing education credit.

Pfizer and the National Bleeding Disorders Foundation (NBDF) – Pfizer Independent Medical Education  RFP: Community Oncology Support for Therapy Management in Multiple Myeloma (MM)

• Due: October 15, 2025
• Funding: Up to $600,000
• Project Period: Up to 2 years
• Purpose: To support Oncologists and other healthcare professionals responsible for the care and treatment of patients with relapsed refractory multiple myeloma. A successful proposal will include multiple organizations collaborating together in the implementation of a new initiative that will guide, teach, and facilitate support for community oncologist and other healthcare professionals caring for MM patients receiving BCMA BsAbs.
• Eligibility: All institutions/departments/organizations making up the collaboration must have a relevant role; the requesting organization must have a key role in the project. U.S.-based medical, nursing, allied health, and/or pharmacy professional schools, healthcare institutions (both large and small), professional organizations/medical societies, medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible. Accreditation is necessary for projects offering continuing education credit.

Pfizer and the National Bleeding Disorders Foundation (NBDF) – Education in the Era of Emerging Hemophilia Therapy (Round 2)

• Due: October 15, 2025
• Funding: Up to $200,000
• Project Period: Up to 2 years
• Purpose: To support local (grass roots) independent medical education initiatives that will result in measurable improvement of the medical and scientific understanding of emerging treatment options for people living with hemophilia and the MDTs that provide them care.
• Eligibility: The PI must be an employee or contractor of the organization submitting an application. U.S.-based medical, nursing, allied health, and/or pharmacy professional schools,  healthcare institutions, PAGs or other non-profit organizations, professional organizations/medical societies, medical education companies, and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible. Accreditation is necessary for projects offering continuing education credit.

November

Aniara Diagnostica  – Coagulation Research Grant

• Due: November 1, 2025
• Funding: $20,000
• Project Period: 1 year
• Purpose: To support innovative research on coagulation/hematology. This year, Aniara is requesting proposals for projects that deal specifically with Ehlers-Danlos syndrome (EDS) and its effects on hemostasis and thrombosis.
• Eligibility: Established researchers (PhD faculty or equivalent), student or trainee at an academic organization or institution in North America or Scandinavia. Applicants with a minimum of three peer-reviewed publications preferred.

Lustgarten Foundation  – Robert F. Vizza Clinical Accelerator Initiative

• Due: November 3, 2025 (LOI)
• Funding: $300,000
• Project Period: Over 3 years
• Purpose: This grant is intended to provide academic, clinical researchers the opportunity to propose science-driven concepts focused on advancing the development of new therapies for pancreatic cancer patients while furthering our understanding of disease biology.
• Eligibility: Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent degree and have a faculty position or equivalent at a college, university, medical institution, or other research facility. PIs should be conducting significant pancreatic cancer and/or related research, have a demonstrated track record of significant contributions to the field, evidenced by publications, peer-reviewed funding and an ability to advance projects to clinical impact. Collaboration with outside institutions including the Lustgarten Translational Advisory Group and other Lustgarten Foundation-Funded Investigators is required.

Cystic Fibrosis Foundation – Medical Resident Research Award

• Due: November 14, 2025
• Funding: Up to $10,000
• Project Period: 1 year
• Purpose: To introduce residents to research through participation in a CF-relevant research project and to spark interest in a career in CF research or as a CF care provider. Priority will be given to projects that will lead to increased understanding of disease mechanisms, pathophysiology, and prevention, and the development of treatment strategies.
• Eligibility: U.S. citizens, permanent residents, or non-U.S. citizens working in a U.S.-based, non-profit or academic institution. Applicants must have completed medical training, hold an MD, DO, or equivalent, and be enrolled in an ACGME accredited residency program in the U.S. for the duration of the award. International applicants must be able to obtain the appropriate visas for application and be certified by the Educational Commission for Foreign Medical Graduates (ECFMG).

American Foundation for Suicide Prevention  – Distinguished Investigator Innovation Grants

• Due: November 15, 2025
• Funding: Up to $150,000
• Project Period: 2 years
• Purpose: To support research by investigators with an established track record of research and publications.
• Eligibility: Researchers at the level of associate professor or higher with an established record of research and publications are eligible.

American Foundation for Suicide Prevention  – Standard Research Innovation Grants

• Due: November 15, 2025
• Funding: Up to $125,000
• Project Period: 2 years
• Purpose: Supports research on suicide from various disciplines.
• Eligibility: Investigators at any level eligible to apply.

American Foundation for Suicide Prevention  – Early Career Researcher Innovation Grants

• Due: November 15, 2025
• Funding: Up to $140,000
• Project Period: 2 years
• Purpose: To support research by early career investigators working under the guidance of a mentor. Funding includes $14,000 over 2 years for a mentor.
• Eligibility: Applicants at or below the level of an assistant professor may apply.

American Foundation for Suicide Prevention  –  Postdoctoral Research Fellowship Innovation Grants

• Due: November 15, 2025
• Funding: Up to $140,000
• Project Period: 2 years
• Purpose: To support early-career investigators. Funding includes an annual stipend of $56,000 and an institutional allowance of $14,000.
• Eligibility: Investigators who received a PhD, MD or equivalent degree within the past six years with no more than three years of fellowship support may apply.

American Foundation for Suicide Prevention  – Pilot Innovation Grant

• Due: November 15, 2025
• Funding: Up to $50,000
• Project Period: 2 years
• Purpose: To provide seed funding for new projects (typically feasibility studies) that have the potential to become larger research studies.
• Eligibility: Investigators at any level are eligible.

Cancer Research Institute – CRI Technology Impact Award

• Due: November 15, 2025 (LOI)
• Funding: $300,000
• Project Period: 2 years
• Purpose: To support collaborations between technology, developers and clinical cancer immunologists to generate proof-of-principle of a novel platform technology in bioinformatics that can accelerate the field’s efforts in developing immunotherapies that are effective for all cancer patients.
• Eligibility: Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation or provide documentation from their institution along with the Letter of Intent confirming they will hold the position of assistant professor or higher by the time of award start date.

GenScript – GenScript Life Science Research Grant Program (LSRG Program)

• Due: November 15, 2025
• Funding: $100,000
• Project Period: 1 year
• Purpose: To help accelerate projects with potential for impact and breakthrough, by leveraging GenScript’s existing resources and capabilities.
• Eligibility: Projects must demonstrate strategic alignment with GenScript’s primary areas of scientific interest.

The Gerber Foundation – Spring Grant Round – Novice Grants Only

• Due: November 15, 2025 (Concept papers due)
• Funding: $30,000
• Project Period: Not specified
• Purpose: To support projects that focus on infants and children. Priority will be given to projects that when implemented, will improve nutrition, care and development of infants and young children from the first year before birth to three years of age.
• Eligibility: Applicants may be physicians, PhD candidates, PharmD candidates, and equivalent (and individuals in a residency, postdoctoral, or fellowship training program or those with no more than one year post training). K01 awardees are not eligible. An assigned mentor is required.

KidneyCure – KidneyCure Transition to Independence Grants Program

• Due: November 20, 2025
• Funding: $75,000
• Project Period: 1 year
• Purpose: To provide support for the development and career advancement to research independence of young faculty in the field.
• Eligibility: Active ASN members with and MD, DO, PhD or equivalent working in North America, Central America, or the Caribbean, who are within 10 years of their initial faculty appointment. Appointment to full-time faculty and support as an independent researcher must be confirmed by the department chair. The proposed project must be independent of previous projects with a mentor. Applicants may not have more than $250,000 in annual direct costs in external grant support (including KidneyCare funds), at the time of the award. 75% protected time required.

December

American Cancer Society – Clinician Scientist Development Grant (CSDG)

• Due : December 1, 2025
• Funding: $135,000 a year
• Project Period: 3 to 5 years
• Purpose: Supports full-time clinician faculty members in becoming independent investigators as clinician scientists.
• Eligibility: Applicants who work at a US academic institution or eligible non-profit  who have a doctoral degree and active clinical license who participate in clinical care and are not a current or former principal investigator of an individual mentored training grant and have not been a PI on an R-level or equivalent grant are eligible.

American Cancer Society – Postdoctoral Fellowships (PF)

• Due : December 1, 2025
• Funding: $66,000, $68,000, and $70,000, plus $4,000 fellowship annually (plus $1,500 travel allowance in final year)
• Project Period: Up to 3 years
• Purpose: To support new investigators in research training programs to position them for independent careers in cancer research.
• Eligibility: Applicants with doctoral degrees (less than 4 years) who do not have a faculty appointment and work at a US academic institution or eligible non-profit are eligible. U.S. citizenship, permanent residency, or appropriate visa when you submit your application is required.

American Cancer Society – Research Scholar Grants

• Due : December 1, 2025
• Funding: Up to$215,000 per year
• Project Period: Up to 4 years
• Purpose: To support independent, self-directed researchers working at an U.S. academic institution or eligible non-profit organizations.
• Eligibility: Awards available to support investigators at all levels who have been appointed as independent, full-time faculty less than 10 years ago. Applicant’s institution must provide space and other resources needed by independent investigators.

American Cancer Society – RFA: Leukemia Exploration and Prevention Grant Program (LEAP)

• Due : December 1, 2025
• Funding: Up to $430,000 per year
• Project Period: Up to 4 years
• Purpose: RUNX1 Research Program and the American Cancer Society (ACS) have partnered to support projects that deepen our understanding of the mechanisms that cause each leukemogenic step (projects should consider experimental designs that address both cell-autonomous and cell-nonautonomous factors), and projects that are high-risk with strong scientific rationale to pursue a cancer interception treatment.
• Eligibility: PIs/teams must work at a U.S. academic institution or eligible non-profit organization and can be full-time independent investigators at any career stage.
  LEAP-Research Scholar Grant – supports an independent research project (up to $215,000 per year for independent, self-directed researchers).
• LEAP Team Award – supports an interdisciplinary, synergistic team research project that will accelerate scientific advancement and clinical benefit (up to $430,000 per year).

American College of Gastroenterology (ACG) Institute for Clinical Research and Education  & American College of Gastroenterology – 2026 Junior Faculty Development Award

• Due : December 1, 2025
• Funding: $450,000
• Project Period: 3 years
• Purpose: To support junior investigators pursuing independent clinical research careers in gastroenterology or hepatology.
• Eligibility: ACG members who are full-time junior faculty (less than 7 years post GI or Hepatology fellowship training) at a U.S.- or Canadian-based university, medical school or health care institution who hold an MD, MBBS, or DO are eligible. 50% protected time and a preceptor who can provide mentorship is required.

American College of Gastroenterology (ACG) Institute for Clinical Research and Education & American College of Gastroenterology – 2026 Established Investigator Bridge Funding Award RFA

• Due : December 1, 2025
• Funding: $300,000
• Project Period: 2 years
• Purpose: To provide short-term support for established clinical gastroenterology or hepatology investigators while they await federal program funding for their independent research program.
• Eligibility: ACG members who are U.S.- or Canadian-based physicians working as full-time faculty in a astroenterology or hepatology department at a university, medical school or other healthcare institution university. Evidence of recently concluded federal clinical or translational research award as the PI within the last 3 years in gastroenterology or hepatology, such as NIH R01, K-award, or VA Merit Award. National Science Award, Department of Defense and CIHR multi-year project grant awards of equivalency will be considered. Applicants must provide evidence of an ongoing renewal application for federal funding (eRA commons routing information or letter of intent from institutional grant awards office). A letter from the Division Chief or Department Chair must certify that the award will provide 30% protected time to the recipient regardless of the amount budgeted for salary under the terms of the award.

American Lung Association  & American Academy of Allergy, Asthma & Immunology (AAAAI) – Allergic Respiratory Diseases Research Award

• Due : December 1, 2025
• Funding: $75,000 per year
• Project Period: Up to 2 years
• Purpose: To increase research in academic allergy and immunology divisions to increase research that will lead to improved care and outcomes for patients with allergic respiratory disease.
• Eligibility: Applicants must have completed training, hold a doctoral degree, be in a clinical Allergy and Immunology Division (or Clinical Immunology Division), and be focused on a project related to allergic respiratory disease. 2nd year funding based on annual review.

American Lung Association  & American Academy of Allergy, Asthma & Immunology (AAAAI) – Catalyst Research Award

• Due : December 1, 2025
• Funding: $50,000 per year
• Project Period: Up to 2 years
• Purpose: To support mentored research by outstanding early career faculty investigators pursuing research independence who are researching the mechanisms of lung disease and general lung biology. Preference will be given to projects that are novel, innovative in design/approach, use modern technologies, and involve a multidisciplinary, collaborative training plan.
• Eligibility: Applicants must work in the U.S. and hold a PhD, MD, DO, DSc , or equivalent and be affiliated with a recognized academic of not-for-profit institution. Postdoctoral and medical fellows seeking to complete at least two years of mentored research training are eligible. MD or DO applicants must have completed two years of research training after receiving their terminal degree prior to the start of the award. The institution must certify that the applicant’s employment is expected to continue through the full duration of the project. Mentors must have a demonstrated history of research experience and mentorship. Awardees of NIH K08, K23, K99 or similar are not eligible.

American Lung Association  – Hastings Innovation Award for Interstitial Lung Disease Award

• Due : December 1, 2025
• Funding: $75,000 per year
• Project Period: Up to 2 years
• Purpose: To support highly promising investigators with stellar track records of accomplishment, who have the potential to advance the field of lung disease science.
• Eligibility: Investigators must hold a doctoral degree, have a full‐time faculty or professional appointment equivalent with demonstrated institutional commitment in a recognized academic or other non‐for‐profit research institution, have demonstrated prior excellence and productivity in the early stages of their careers and must have held a K or R type award within five years preceding application for this award. Individuals who have been Pl on three or more large federal research grants (even those with multiple PIs (i.e. RO1,UO1, PO1, and VA Merit) in their career are not eligible to apply. This restriction does not apply to Co-Investigator roles.

American Lung Association  –  Innovation Award

• Due : December 1, 2025
• Funding: $75,000 per year
• Project Period: Up to 2 years
• Purpose: To support highly promising investigators with stellar track records of accomplishment, who have the potential to advance the field of lung disease science.
• Eligibility: Investigators with prior demonstration of excellence and productivity in the early stages of their careers who have held a K or R type award within five years preceding this award and hold a doctoral degree and a full‐time faculty or professional appointment equivalent with demonstrated institutional commitment (confirmed by a letter from the department chair) are eligible. Individuals who have been Pl on three or more large federal research grants (even those with multiple PIs (i.e. RO1,UO1, PO1, and VA Merit) in their career are not eligible to apply. This restriction does not apply to Co-Investigator roles.

Association for the Advancement of Blood & Biotherapies  – Early Career Scientific Research Grants Program

• Due : December 1, 2025
• Funding: Up to $100,000
• Project Period: Up 2 years
• Purpose: To support investigator-initiated original research related to blood banking, transfusion medicine and biotherapies with a strong likelihood of yielding meaningful data, and to fund researchers on a path towards research independence. Innovative proposals and new projects will be given priority.
• Eligibility: Early career investigators who have completed a terminal research degree or medical residency within 10 years of grant application submission deadline (MD or PhD, medical technologist, transfusion medicine or biotherapies professional), and has not yet been awarded a substantial grant (such as an R01) are eligible to apply

Cancer Research Institute – Clinic & Laboratory Integration Program (CLIP)

• Due : December 1, 2025 (LOI)
• Funding: $300,000
• Project Period: 2 years
• Purpose: To support pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation (CF), CRI also invites LOIs focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine.
• Eligibility: : Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher) at the time of award start date and be qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.

Cancer Research Institute – CRI Clinical Innovator

• Due : December 1, 2025 (Initial Protocol Concept)
• Funding: Up to $1M
• Project Period: 2 years
• Purpose: To support clinician-scientists aiming to launch novel, innovative phase I/II or phase II clinical studies using novel immunotherapies that have potential to have great clinical impact. Competitive applications will have a strong focus on yielding mechanistic insights into clinical response and potentials for biomarker discovery and/or validation.
• Eligibility: An applicant must be the PI of the proposed study affiliated with a medical school or research center. For profit organizations are not eligible.

American Association for Thoracic Surgery  – Alain Carpentier Honoring Our Mentors Program

• Due : December 2, 2025
• Funding: Up to $45,000
• Project Period: Up to 2 years
• Purpose: To support original translational and clinical research to promote treatment advances in valvular heart disease, with strong encouragement for applicants to submit proposals focused on research in patient care in developing countries or areas in the U.S. with deprivation. Areas of scientific interest should include non-thrombogenic solutions to valve disease and projects focused on research in patient care/treatment.
• Eligibility: Applicants must be cardiac surgical residents currently enrolled in an accredited I6 program or general surgery residents intending to follow either a traditional 5-2 training pathway or a 4-3 Early Specialization Program in cardiothoracic surgery in the U.S. or Canada, be engaged in cardiac research in the lab of an established cardiac surgical investigator who is an active AATS member who will serve as their mentor for the duration of the project, and must submit a complete education plan on the proposed research along with adequate documentation outlining their mentor’s involvement and backing of the project.

American Association for Thoracic Surgery  – Cardiac Surgical Resident Investigator

• Due : December 2, 2025
• Funding: Up to $40,000 per year
• Project Period: Up to 2 years
• Purpose: To support clinical and translational research initiatives conducted by cardiac surgical resident investigators, including, but not limited to, topics related to quality and outcomes research, studies of new and innovative therapies, procedures, and technologies in cardiothoracic surgery in the lab of an established cardiac surgical investigator who is an active AATS member who will serve as their mentor for the duration of the project.
• Eligibility: Applicants must be  cardiac surgical residents enrolled in an I6 program, or general surgery residents intending to follow either a traditional 5-2 training pathway or a 4-3 Early Specialization Program in cardiothoracic surgery. Timing of the research interval during the resident’s training years can occur at variable times (for I6 residents, between years 3 and 4. For residents in the traditional or early specialization pathway, between the General and Thoracic Surgical residency years). For programs in the U.S. or Canada.

American Association for Thoracic Surgery  – David J. Sugarbaker Surgical Resident Investigator Award

• Due : December 2, 2025
• Funding: Up to $40,000 per year
• Project Period: Up to 2 years
• Purpose: To support clinical and translational research initiatives conducted by cardiac surgical resident investigators, including, but not limited to, topics related to quality and outcomes research, studies of new and innovative therapies, procedures, and technologies in cardiothoracic surgery in the lab of an established thoracic surgical investigator who will serve as their mentor for the duration of the project.
• Eligibility: Applicants must be residents currently enrolled in an accredited training program in the U.S. or Canada and who have completed at least two years of postgraduate training in a surgical discipline. Mentors for this project must be active members of AATS in good standing.

American Association for Thoracic Surgery  – Surgical Investigator Program

• Due : December 2, 2025
• Funding: Up to $50,000/year
• Project Period: Up to 2 years
• Purpose: To support clinical and translational research by early career cardiothoracic surgeons, including topics related to quality and outcomes research, and studies of new and innovative therapies, procedures, and technologies in cardiothoracic surgery.
• Eligibility: Applicants must have completed their formal training in cardiothoracic surgery (with their cardiothoracic residency completed within 7 years of application), be certified or in the process of obtaining certification by the appropriate Thoracic Surgery Board in the U.S., Canada or international equivalent, and have a current academic or hospital appointment at a U.S. or Canadian institution.

RUNX1 Research Grant Program & Alex’s Lemonade Stand Foundation for Childhood Cancer – RUNX1 RARE Grant Program – Research Accelerating RUNX1 Exploration

• Due : December 11, 2025
• Funding: $250,000
• Project Period: Over 2 years
• Purpose: To fund research that will accelerate development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevent blood cancer (before clonal hematopoiesis).
• Eligibility: Applicants must have MD, PhD, MD/PhD (DO, MBBS or equivalent) and research experience working in, and a deep understanding of, normal or malignant hematopoiesis and/or immunology. Funds will be granted to non-profit organizations only. PIs can have other grants during the award period but must provide clear documentation of mechanisms to avoid scientific and budgetary overlap.

Jay L. Smith Foundation – Grants

• Due : December 31, 2025 (pre-proposal)
• Funding: Not specified
• Project Period: 1 year
• Purpose: To support research, programs, education and outreach in various areas to include dementia & Alzheimer’s disease, health care access and delivery, elderly care, suicide prevention, and cancer research.
• Eligibility: U.S.-based nonprofit organizations may apply.

Awards

October

American Academy of Neurology – Wayne A. Hening Sleep Medicine Investigator Award

• Due : October 21, 2025
• Prize: $1,000
• Project Period: Not specified
• Purpose:  The award is sponsored by the American Academy of Neurology and endowed by UCB, Inc., Lilly USA, Elite Home Medical & Respiratory, Inc., Raleigh Neurology Associates, and friends of Dr. Wayne A. Hening. It rewards productivity of early career investigators  and emphasizes the essential role of neurology in sleep medicine. Recipient is expected to give a 10-minute presentation based on the selected manuscript during a scientific session at the 2026 AAN Annual Meeting.
• Eligibility: Applicants must be no more than 10 years from completion of most recent training program and no higher than the rank of assistant professor. Board certification and AAN membership not necessary. Industry employees are not eligible.

December

Challenge  Works, the Motor Neurone Disease Association & partners – Longitude Prize on ALS

• Due : December 3, 2025
• Prize: Up to $10M
• Project Period: 5 years
• Purpose: An international program that seeks to incentivize the use of AI-based approaches to transform therapeutic discovery for treating amyotrophic lateral sclerosis (ALS) by global multidisciplinary teams to identify, prioritize, and validate high-potential drug targets.
• Eligibility: AI experts, computational biologists and bioinformaticians, neurodegenerative disease and ALS researchers, Biotechnology, techbio and pharmaceutical companies, Data scientists and engineers, and clinical experts and medical researchers may apply.